- Home
- TILE vs RXST Comparison
TILE vs RXST Comparison
Compare TILE & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TILE
- RXST
- Stock Information
- Founded
- TILE 1973
- RXST 1997
- Country
- TILE United States
- RXST United States
- Employees
- TILE N/A
- RXST N/A
- Industry
- TILE Home Furnishings
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TILE Consumer Discretionary
- RXST Health Care
- Exchange
- TILE Nasdaq
- RXST Nasdaq
- Market Cap
- TILE 1.1B
- RXST 1.0B
- IPO Year
- TILE N/A
- RXST 2021
- Fundamental
- Price
- TILE $18.58
- RXST $14.43
- Analyst Decision
- TILE Buy
- RXST Buy
- Analyst Count
- TILE 1
- RXST 10
- Target Price
- TILE $30.00
- RXST $38.50
- AVG Volume (30 Days)
- TILE 611.2K
- RXST 1.2M
- Earning Date
- TILE 05-02-2025
- RXST 05-07-2025
- Dividend Yield
- TILE 0.22%
- RXST N/A
- EPS Growth
- TILE 94.74
- RXST N/A
- EPS
- TILE 1.48
- RXST N/A
- Revenue
- TILE $1,315,658,000.00
- RXST $139,927,000.00
- Revenue This Year
- TILE $4.21
- RXST $24.34
- Revenue Next Year
- TILE $5.25
- RXST $21.83
- P/E Ratio
- TILE $12.55
- RXST N/A
- Revenue Growth
- TILE 4.29
- RXST 57.09
- 52 Week Low
- TILE $14.13
- RXST $13.50
- 52 Week High
- TILE $27.34
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- TILE 42.38
- RXST 25.56
- Support Level
- TILE $17.96
- RXST $13.79
- Resistance Level
- TILE $19.22
- RXST $14.93
- Average True Range (ATR)
- TILE 1.01
- RXST 1.34
- MACD
- TILE 0.01
- RXST -0.29
- Stochastic Oscillator
- TILE 42.54
- RXST 9.78
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.